Prevention of NCDs Through Screening and Educating Individuals on Health-risk Behaviours in the Community
Prevention of Non-communicable Diseases Through Screening and Educating Individuals on Health-risk Behaviours in the Community
1 other identifier
interventional
330
1 country
1
Brief Summary
Aim: to prevent NCDs by screening and educating individuals in the community on health-risk behaviours. Specifically, we will use a mobile health and a brief self-determination theory-based intervention in helping individual change their health-risk behaviours. Hypotheses to be tested: compared with those in the control group, the participants in the intervention group will experience significantly greater success in modifying their health-risk behaviours and will have a better health-related quality of life at 12 months follow-up. Objectives
- 1.To screen individuals for health-risk behaviours and identify risk factors that may contribute to NCDs
- 2.To educate individuals on the importance of engaging in healthy lifestyles
- 3.To develop a training programme - "Train the Trainers' Toolkit", with the goal to train student nurses (Years 2 to 5) as health ambassadors to implement the project on a long-term basis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2023
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedStudy Start
First participant enrolled
July 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedMarch 19, 2026
March 1, 2026
1.7 years
March 16, 2023
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abstain from health-risk behaviour
About 10% of participants will successfully abstain from at least one health-risk behaviour at 12-month follow-up
12 months
Secondary Outcomes (5)
Reduction in health-risk behaviours
12 months
Improvement in health-related quality of life
12 months
Ambassadors' knowledge and skill on providing professional health advice and support to participants about changing their health-risk behaviours
6 months
Improvement in blood pressure
12 months
Improvement in body mass index
12 months
Study Arms (2)
Intervention group
EXPERIMENTALThe participants will also be given a Practical Resource Hub for Healthy Life leaflet containing information on various applications. The participants will receive a brief telephone intervention using the Ask, Warn, Advise, Refer and Do-it-again (AWARD) model. For the advice step, the research assistant will ask about the priority the participants place on engagement in desirable health-related lifestyle practices identified in the completed behavioural risk factor survey. The participants will also be asked to choose the goal that they consider easiest to achieve, such as quitting or reducing smoking, consuming more vegetables or less fatty foods or sugary drinks, performing more exercise or reducing alcohol consumption. The participants will be encouraged to quit health-risk behaviours (or adopt a healthy lifestyle) sequentially, but they will also be able to choose to quit them simultaneously if they are confident in doing so.
Control group
PLACEBO COMPARATORThe control group participants will also be given a Practical Resource Hub for Healthy Life leaflet containing information on various applications. However, the health ambassadors will simply advise the participants to modify their health-risk behaviours and/or adopt a healthy lifestyle practice. The participants will also receive follow-up for outcome assessments with the same schedule as those in the intervention group.
Interventions
The participants will be simply advised to modify their health-risk behaviours and/or adopt a healthy lifestyle practice. The participants will also receive follow-up for outcome assessments with the same schedule as those in the intervention group.
The participants will also be asked to choose the goal that they consider easiest to achieve and encouraged to quit health-risk behaviours. The research assistant will assist in achieving the participant's health-related goals by sending WhatsApp/WeChat messages or via telephone calls once per week for the first 6 months.
Eligibility Criteria
You may qualify if:
- Chinese adults in Kwai Chung Estate:
- age ≥18 years
- the presence of at least one health risk behaviour (tobacco use, harmful use of alcohol, unhealthy diet and physical inactivity)
- able to communicate in Cantonese
- Nursing students:
- age ≥18 years
- Year 2 to 5
You may not qualify if:
- poor cognitive state or mental illness
- participation in another related study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ho Cheung William Li, PhD
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 16, 2023
First Posted
March 30, 2023
Study Start
July 13, 2023
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the project has been completed and the results of the project has been published
- Access Criteria
- Request could be sent to Principal Investigator (williamli@cuhk.edu.hk)
The relevant anonymized patient level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.